BioCentury | May 11, 2018
Finance

Seroquel stepping stone

...in its CNS pipeline. The most advanced are LY03003, an extended release microsphere formulation of rotigotine...
BioCentury | May 11, 2018
Company News

Luye acquires AstraZeneca antipsychoitic for $538M

...company is also developing LY03003 to treat Parkinson's disease. It is an extended-release formulation of rotigotine...
BioCentury | May 7, 2018
Company News

Luye paying AZ $538M for antipsychotic

...company is also developing LY03003 to treat Parkinson's disease. It is an extended-release formulation of rotigotine...
BioCentury | Oct 29, 2015
Company News

UCB gains after boosting guidance

...of its growth to increased sales of Cimzia certolizumab pegol , Vimpat lacosamide and Neupro rotigotine...
...response mediator protein-2 ( DPYSL2 ; CRMP-2 ), is approved to treat epilepsy and seizures. Neupro...
BioCentury | Sep 7, 2015
Strategy

Back to School 2015: Changing the subject

No longer content with a walk-on role as research subjects, and empowered by access to more information and the necessity of shouldering a bigger share of the healthcare bill, patients are demanding a speaking role...
BioCentury | Jun 22, 2015
Clinical News

Neupro rotigotine: Phase III data

...trial in 247 adults with early stage idiopathic PD showed that once-daily 2-8 mg transdermal Neupro...
...motor examination subscales from baseline to week 24 vs. placebo (4.9 vs. 0.2 points, p<0.0001). Neupro...
...UAE UCB Group (Euronext:UCB), Brussels, Belgium Otsuka Pharmaceutical Co. Ltd. , Tokyo, Japan Product: Neupro rotigotine...
BioCentury | Jun 17, 2015
Clinical News

UCB's Neupro meets in Chinese Phase III PD trial

...UCB Group (Euronext:UCB) reported detailed data from a Phase III trial of Neupro rotigotine in Chinese...
...regulatory application in China this year for the dopamine receptor agonist patch to treat PD. Neupro...
...change from baseline was -4.9 in the Neupro arm vs. -0.2 in the placebo arm. Neupro...
BioCentury | Oct 27, 2014
Finance

Waiting for better times

...of autoimmune drug Cimzia certolizumab pegol were up 36% to €561M ($711.6M); sales of Neupro rotigotine...
BioCentury | Aug 4, 2014
Finance

Voucher leapfrog

...of autoimmune drug Cimzia certolizumab pegol were up 35% to €353M ($481.8M); sales of Neupro rotigotine...
BioCentury | Apr 28, 2014
Finance

Venture hots up

...36% to €160M ($221.2M); epilepsy drug Vimpat lacosamide, up 23% to €105M ($145.2M); and Neupro rotigotine...
Items per page:
1 - 10 of 127